‘You have to have the goods’: Retiring Vir CEO George Scangos on building great companies

He built companies across cancer, spinal muscular atrophy and an accelerate treatment for Covid-19 and, potentially, other major infectious diseases at three multibillion-dollar drug developers. Now he's handing Vir's reins to outgoing Bayer exec Marianne De Backer.

Previous Banking special report: PNC's Oregon boss looks to 2023 as bank tries to tighten local ties
Next UCM Digital Health and MVP Health Care launch new ER telemedicine program

No Comment

Leave a reply

Your email address will not be published. Required fields are marked *